CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company's ...

Moderna plans to continue evaluating mRNA-1647 in an ongoing Phase 2 trial for bone marrow transplant patients, where the vaccine could potentially suppress disease associated with CMV reactivation.

Oct 22 (Reuters) - Moderna (MRNA.O), opens new tab said on Wednesday it would stop developing its experimental vaccine to prevent cytomegalovirus, a virus that can cause birth defects, after it failed ...

In a nation where the smartphone rarely leaves the palm, while the TV’s on in the background, new research from Nielsen Consumer & Media View (CMV) reveals Australians are not abandoning traditional ...

BELGRADE: The United States has introduced sanctions against Serbia’s main oil supplier, which is controlled by Russia, the company said on Thursday. Serbia almost entirely depends on Russian gas and ...

Investing.com -- Moderna Inc. (NASDAQ:MRNA) stock fell 5% in after-hours trading Wednesday following the company’s announcement that its cytomegalovirus (CMV) vaccine candidate failed to meet its ...

Abstract: The conventional reduced-common-mode-voltage model predictive control (RCMV-MPC) faces the challenges of low control accuracy and high switching frequency at low speeds. To reduce CMV, ...

Abstract: Exploiting the rich switching redundancies of the dual inverter, new hybrid pulsewidth-modulation (PWM) switching methods are proposed in this paper using the degree of freedom of operating ...

Police say the CMV was travelling at 120 kilometres per hour in a posted 80 zone on County Road 27 near Baseline Road. The 32-year-old male driver from Chatham was ticketed for speeding and the ...

bDepartment of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA cInstitute of Chinese Medical Sciences, University of Macau, ...